ASX code: STI
Listing Date: Thu, 24 Jul 1997
Industry: Pharmaceuticals, Biotechnology & Life Sciences
Principal Activities:
Commercialising patented beta agonist Repartitioning Feed Enhancers ('RFEs') for livestock, which are being positioned as replacement products and alternatives to the use of antibiotics and hormones as growth promoters.
Address:
28 The Esplanade, BGC Centre, Level 11
PERTH
WA 6000
Phone: 08 9480 1480
Fax: 08 9226 4144
Executives & Directors
Prof. Clive P Page, Non Exec. Chairman, Non Exec. Director
Dr Calvin London, Managing Director
Mr Simon Robertson, Company Secretary
Please contact the ASX to change these details
Company Podcasts
Subscribe to current and future audio events for this company by clicking on the podcast icon:
Company ASX Announcements
Company ASX announcements can be viewed on the ASX website.
Announcements from the preceding six months are shown below.
View this company's details on the Australian Securities Exchange website
STIRLING PRODUCTS LIMITED (STI) Events
| Company (Stock Code) | Date/Time | Event | Timezone: Australia/NSW |
|---|---|---|---|
|
Wed, 6 Aug 2008 11:30AM |
STI - Shareholder Update 2nd Quarter 2008 - Dr Calvin London, MD |
     |
|
Wed, 23 Apr 2008 04:00PM |
Excellence in Biotechnology Investment - Dr Calvin London, MD, Stirling Products Ltd |
|
|
|
Tue, 22 Apr 2008 10:30AM |
STI - Shareholder Update 1st Quarter 2008 - Dr Calvin London, MD |
|
|
|
Fri, 23 Nov 2007 01:00PM |
STI - 2007 Annual General Meeting - Dr Calvin London, MD |
|
|
|
Fri, 12 Oct 2007 05:00PM |
STI - Activities Update - Dr Calvin London, MD |
|
|
|
Tue, 31 Jul 2007 10:00AM |
STI - Activities Update - Dr Calvin London, MD |
|
|
|
Tue, 24 Apr 2007 02:00PM |
STI - First Quarter CY 2007 Market Update - Dr Calvin London, MD |
|
|
|
Wed, 7 Feb 2007 12:00PM |
STI - Agreement Signed with North American Bioscience Company - Dr Calvin London, MD |
|
|
Thu, 23 Nov 2006 09:30AM |
STI - Annual General Meeting - Dr Calvin London CEO |
|
|
Tue, 10 Oct 2006 11:00AM |
STI - Update on the Commencement of Several Trials - Dr Calvin London, MD and CEO |
|
|
Mon, 28 Aug 2006 04:00PM |
STI - R-Salbutamol Adds Substantial Weight Gain to Lambs - Dr Calvin London, Managing Director |
|
|
Mon, 17 Jul 2006 03:00PM |
STI - European Joint Venture - Dr Calvin London, MD & CEO |
|
|
Fri, 26 May 2006 10:30AM |
STI - Animal Growth Promoters - Dr Calvin London, Managing Director and CEO |
|
| Fri, 21 Nov 2008 01:00PM 01:00PM Australia/WA |
Annual General Meeting Plaza Level, BGC Centre, 28 The Esplanade, Perth, WA
|
||
| Tue, 21 Oct 2008 | Full Year Results | ||
| Fri, 29 Feb 2008 | Interim Results | ||
| Fri, 23 Nov 2007 10:00AM |
Annual General Meeting BGC Centre, 28 The Esplanade Perth WA
|
||
| Wed, 29 Aug 2007 | Full Year Results | ||
| Fri, 23 Feb 2007 | Interim Results | ||
| Wed, 22 Nov 2006 11:00AM |
Annual General Meeting Mezzanine Level, BGC Centre, 28 The Esplinade Perth WA
|
||
| Fri, 8 Sep 2006 | Full Year Results | ||
| Fri, 31 Mar 2006 | Date Payable | ||
| Thu, 16 Mar 2006 | Interim Results | ||
| Thu, 24 Nov 2005 10:00AM 10:00AM Australia/WA |
Annual General Meeting | ||
  Displaying 1-20 of 24 events
|
|||
STIRLING PRODUCTS LIMITED (STI)
| FINANCIAL UPDATE | Tue, 23 Dec 2008 |
| Trading Halt | Mon, 22 Dec 2008 |
| Capital Raising | Fri, 21 Nov 2008 |
| Amendment to Announcement Date Re Capital Raising | Fri, 21 Nov 2008 |
| RESULTS FROM ANNUAL GENERAL MEETING | Fri, 21 Nov 2008 |
| Stirling Consolidates Licensing Deals | Mon, 10 Nov 2008 |
| STIRLING GETS FIRST APPROVAL FOR OBESITY PATENT | Fri, 7 Nov 2008 |
| Appendix 4C Quarterly report | Fri, 31 Oct 2008 |
| Correction to Resolution 7 in the Notice of AGM | Thu, 30 Oct 2008 |
| Notice of Annual General Meeting/Proxy Form | Tue, 21 Oct 2008 |
Please note: This company appears on this website as a result of its listing on the Australian Securities Exchange. Boardroom Radio does not claim any association with any company listed on this site.
